accountKKR agreed to acquire Pfizer���s Capsugel business for $2.38 billion in cash. Pfizer said in October it was reviewing options for Capsugel, which makes capsules and other drug-delivery systems. Capsugel, which generated abut...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Deal Profile: KKR to Buy Pfizer���s Capsugel Unit for $2.4 Billion
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account